Loading decisions…
Loading decisions…
46,961 vetted Board decisions for Ischemic heart disease.
The Board remands the claim for a new VA examination to determine the current severity of the service-connected hypertensive heart disease.
The Board denied the veteran's claims for earlier effective dates and higher ratings for his service-connected conditions, as well as a TDIU.
The Board dismissed the appeal for service connection for COPD and denied earlier effective dates on a presumptive basis for diabetes mellitus, but granted an earlier effective date for coronary artery disease. The Board also granted an increased rating from August 10, 2022 for diabetes mellitus.
The Board granted service connection for type II diabetes mellitus, hypertension under the PACT Act, and diabetic nephropathy. The claims for a heart condition, bilateral upper extremity diabetic neuropathy, and bilateral lower extremity diabetic neuropathy were also granted. The claim for erectile dysfunction was remanded.
The Board granted service connection for a heart disability, to include coronary artery disease (CAD), due to conceded herbicide agent exposure.
The Board granted service connection for atrial fibrillation as secondary to the Veteran's service-connected asthma, but remanded the issue of a heart disability, to include supraventricular arrhythmia, other than atrial fibrillation.
The Board remands the claims for service connection for various conditions due to a lack of verification of the Veteran's claimed Vietnam service.
The Board remands the Veteran's claims for a higher rating for coronary artery disease and entitlement to TDIU due to insufficient evidence.
The Board granted service connection for a heart condition and the Veteran's cause of death, resolving reasonable doubt in favor of the appellant.
The Board granted service connection for valvular heart disease with supraventricular arrhythmia and coronary spasm, resolving reasonable doubt in favor of the Veteran based on exposure to commercial herbicides during service.
The Board denied service connection for diabetes mellitus, erectile dysfunction, hypertension, heart disorder, and peripheral neuropathy of the upper and lower extremities as there was no evidence to support a link between these conditions and the Veteran's military service.
The Board remands the claim for a heart disorder, to include mitral valve prolapse, for further development of evidence.
The Board granted service connection for coronary artery disease, diabetes mellitus type 2, right and left lower extremity peripheral neuropathy, and diabetic nephropathy/kidney disability. Mixed hyperlipidemia was denied.
The Board remands the claims for service connection for a heart disability, left sciatic nerve damage, and right sciatic nerve damage to address the Veteran's contention of exposure to environmental toxins while deployed in South Korea.
The Board granted a 60 percent disability rating for coronary artery disease from March 23, 2005, to January 2010 and an effective date of March 23, 2005, for the award of total disability based upon individual unemployability due to service-connected disabilities.
The Board denied service connection for arteriosclerotic heart disease with congestive heart failure, automatic implantable cardioverter defibrillator, heart block, cardiomyopathy, and senile cardiac amyloidosis as the evidence did not support a finding that these conditions were incurred in or aggravated by active service.
The veteran withdrew all pending appeals, and the Board has no jurisdiction to review these issues.
The Board denied a compensable initial rating for right ear hearing loss and an initial rating greater than 30 percent for coronary artery disease, congestive heart failure, and old myocardial infarction.
The Board remands the claims for service connection for bilateral arthritis of the hands, fibromyalgia, and coronary artery disease due to pre-decisional duty to assist errors.
The veteran was granted a 30 percent disability rating for valvular heart disease with premature ventricular contractions from July 9, 2024, to July 14, 2024, but denied an increased rating prior to that date.
← Back to Ischemic heart disease overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.